glp-1 before pregnancy Study finds no major early risks tied to drugs, but doctors still advise against use If you're on a GLP-1

doi: 10.1016/j.metabol.2012.03.002 21 HernandezA

Studies on opioids have yielded mixed results, with some reporting a decrease in opioid self-administration with GLP-1 receptor agonist treatment, while others have found no significant effects

64 SEMA has demonstrated clear clinical improvements in MASLD/MASH and allows use beyond the instructions, particularly in patients with T2DM and obesity

Its multi-receptor activation profile distinguishes it from amylin analogs like Cagrilintide

The brain-protective effects that may reduce dementia risk, along with improvements in sleep quality and joint pain, address multiple health concerns through a single treatment approach

Without a delivery system like liposomes, much of the supplement is lost during digestion